Valuation dashboard for NeuroOne Medical Technologies Corporation (NMTC) with P/E N/A, P/B 3.38, EV/EBITDA -1.84 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems.
Analysis Summary
NeuroOne Medical Technologies Corporation reported revenue of $12.1M in the most recent fiscal year, growing at a 5-year CAGR of 44.4%.
Trailing-twelve-month margins: gross margin 55.7%, operating margin -76.1%, net margin -71.5%.
At the current price of $1.41, NMTC has negative trailing earnings (P/E not meaningful) and an ROE of -126.45%. Market capitalisation stands at $12M.
Balance sheet quality for NMTC: current ratio of 4.4. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 3.38 |
| EV / EBITDA | -1.84 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-188.58 |
| vs Current Price | -13474.4% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NMTC | NeuroOne Medical Technologies Corporation | $12M | 3.38 | -126.4% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $1.41 |
| Market Cap | $12M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -126.45% |
| Return on Invested Capital | -183.45% |
| Return on Assets | -115.57% |
| Gross Margin | 55.67% |
| Operating Margin | -76.05% |
| Net Margin | -71.51% |
Related companies: ATHE · BDMD · CTSO · ECOR · HYPD · MYO · RBOT
Explore sector: Healthcare · Medical - Devices
More sections of NMTC: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks